IRWD
Ironwood Pharmaceuticals, Inc. · Healthcare
SVP and Chief Business Officer Andrew Davis sold $147K of Ironwood Pharmaceuticals, Inc.
Sold$146,576
$6.45Price
22,725Shares
−7%Stake
What IRWD did after the filing
- The stock from Wed, May 22 close, $6.49
- +1.2%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Jul 8 close.
Traded Mon, May 20. Filed Wed, May 22, 12:05 PM ET, during the session. Returns use the May 22 close and the Jul 8 close. Not investment advice.